SciTec PhD student Alimohammad Shahri has been successful in securing a BU Graduate School Santander Scholarship Award, to the value of £2,500.
The grant will support Alimohammad to visit three research groups in Europe: the Open University in the UK, Polytechnic University of Valencia in Spain, and Simula Research Lab in Norway.
Alimohammad’s PhD thesis research investigates novel methods for the obtainment and analysis of users’ feedback on the quality of software systems and the utilization of that feedback to improve the service and plan the evolution of a system. The visits will allow Alimohammad to present his work and interact with scholars in the three groups and do joint work especially in the areas of requirements engineering, model-driven development, gamification to motivate users to play an active role in contributing knowledge useful to evolve software, and datamining techniques of users’ feedback to infer their collective judgement on the role of software in meeting their requirements.
Alimohammad’s research is part of the SOCIAD project, funded by an FP7 Marie Curie CIG grant and Bournemouth University, and his supervisory team consists of Dr. Raian Ali, Prof. Keith Phalp and Associated Prof. Jacqui Taylor.
For further information regarding Alimohammad’s research please contact him at ashahri@bournemouth.ac.uk:











3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
Prof Marahatta promoting BU-Nepal collaboration
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease